Detalhe da pesquisa
1.
Prototype and BA.5 protein nanoparticle vaccines protect against Omicron BA.5 variant in Syrian hamsters.
J Virol
; 98(3): e0120623, 2024 Mar 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-38305154
2.
Diet-induced obesity and diabetes enhance mortality and reduce vaccine efficacy for SARS-CoV-2.
J Virol
; 97(11): e0133623, 2023 Nov 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-37846985
3.
Immunogenicity and safety of heterologous Omicron BA.1 and bivalent SARS-CoV-2 recombinant spike protein booster vaccines: a phase 3, randomized, clinical trial.
J Infect Dis
; 2023 Nov 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-37970668
4.
Phase 1-2 Trial of a SARS-CoV-2 Recombinant Spike Protein Nanoparticle Vaccine.
N Engl J Med
; 383(24): 2320-2332, 2020 12 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-32877576
5.
Induction of Cross-Reactive Hemagglutination Inhibiting Antibody and Polyfunctional CD4+ T-Cell Responses by a Recombinant Matrix-M-Adjuvanted Hemagglutinin Nanoparticle Influenza Vaccine.
Clin Infect Dis
; 73(11): e4278-e4287, 2021 12 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-33146720
6.
Immunogenicity of a Fourth Homologous Dose of NVX-CoV2373.
N Engl J Med
; 388(9): 857-859, 2023 Mar 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-36734884
7.
Structural Characterization and Modeling of a Respiratory Syncytial Virus Fusion Glycoprotein Nanoparticle Vaccine in Solution.
Mol Pharm
; 18(1): 359-376, 2021 01 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-33322901
8.
Randomized, Blinded, Dose-Ranging Trial of an Ebola Virus Glycoprotein Nanoparticle Vaccine With Matrix-M Adjuvant in Healthy Adults.
J Infect Dis
; 222(4): 572-582, 2020 07 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-31603201
9.
Neutralization of SARS-CoV-2 Variants B.1.429 and B.1.351.
N Engl J Med
; 384(24): 2352-2354, 2021 06 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-33826819
10.
Intradermal Vaccination With Adjuvanted Ebola Virus Soluble Glycoprotein Subunit Vaccine by Microneedle Patches Protects Mice Against Lethal Ebola Virus Challenge.
J Infect Dis
; 218(suppl_5): S545-S552, 2018 11 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-29893888
11.
Fully Human Immunoglobulin G From Transchromosomic Bovines Treats Nonhuman Primates Infected With Ebola Virus Makona Isolate.
J Infect Dis
; 218(suppl_5): S636-S648, 2018 11 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-30010950
12.
Immunogenicity and safety of a respiratory syncytial virus fusion protein (RSV F) nanoparticle vaccine in older adults.
Immun Ageing
; 14: 8, 2017.
Artigo
em Inglês
| MEDLINE | ID: mdl-28413427
13.
A Randomized, Blinded, Controlled, Dose-Ranging Study of a Respiratory Syncytial Virus Recombinant Fusion (F) Nanoparticle Vaccine in Healthy Women of Childbearing Age.
J Infect Dis
; 213(3): 411-22, 2016 Feb 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-26259809
14.
Improved Titers against Influenza Drift Variants with a Nanoparticle Vaccine.
N Engl J Med
; 378(24): 2346-2348, 2018 06 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-29897849
15.
Immunogenicity and efficacy of XBB.1.5 rS vaccine against EG.5.1 variant of SARS-CoV-2 in Syrian hamsters.
Res Sq
; 2024 Feb 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-38405749
16.
Immunogenicity and safety of a bivalent (omicron BA.5 plus ancestral) SARS-CoV-2 recombinant spike protein vaccine as a heterologous booster dose: interim analysis of a phase 3, non-inferiority, randomised, clinical trial.
Lancet Infect Dis
; 2024 Mar 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-38460525
17.
Three immunizations with Novavax's protein vaccines increase antibody breadth and provide durable protection from SARS-CoV-2.
NPJ Vaccines
; 9(1): 17, 2024 Jan 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-38245545
18.
Diet Induced Obesity and Diabetes Enhance Mortality and Reduces Vaccine Efficacy for SARS-CoV-2.
bioRxiv
; 2023 May 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-36299426
19.
A Brighton Collaboration standardized template with key considerations for a benefit/risk assessment for the Novavax COVID-19 Vaccine (NVX-CoV2373), a recombinant spike protein vaccine with Matrix-M adjuvant to prevent disease caused by SARS-CoV-2 viruses.
Vaccine
; 41(45): 6762-6773, 2023 10 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-37739888
20.
The Matrix-M™ adjuvant: A critical component of vaccines for the 21st century.
Hum Vaccin Immunother
; 19(1): 2189885, 2023 12 31.
Artigo
em Inglês
| MEDLINE | ID: mdl-37113023